Αρχειοθήκη ιστολογίου

Αναζήτηση αυτού του ιστολογίου

Δευτέρα 25 Δεκεμβρίου 2017

Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients A Systematic Review and Meta-analysis

Background:
The prevalence of hypertension is high and is increasing worldwide, whereas the proportion of controlled hypertension is low.
Purpose:
To assess the comparative effectiveness of 8 implementation strategies for blood pressure (BP) control in adults with hypertension.
Data Sources:
Systematic searches of MEDLINE and Embase from inception to September 2017 with no language restrictions, supplemented with manual reference searches.
Study Selection:
Randomized controlled trials lasting at least 6 months comparing the effect of implementation strategies versus usual care on BP reduction in adults with hypertension.
Data Extraction:
Two investigators independently extracted data and assessed study quality.
Data Synthesis:
A total of 121 comparisons from 100 articles with 55 920 hypertensive patients were included. Multilevel, multicomponent strategies were most effective for systolic BP reduction, including team-based care with medication titration by a nonphysician (−7.1 mm Hg [95% CI, −8.9 to −5.2 mm Hg]), team-based care with medication titration by a physician (−6.2 mm Hg [CI, −8.1 to −4.2 mm Hg]), and multilevel strategies without team-based care (−5.0 mm Hg [CI, −8.0 to −2.0 mm Hg]). Patient-level strategies resulted in systolic BP changes of −3.9 mm Hg (CI, −5.4 to −2.3 mm Hg) for health coaching and −2.7 mm Hg (CI, −3.6 to −1.7 mm Hg) for home BP monitoring. Similar trends were seen for diastolic BP reduction.
Limitation:
Sparse data from low- and middle-income countries; few trials of some implementation strategies, such as provider training; and possible publication bias.
Conclusion:
Multilevel, multicomponent strategies, followed by patient-level strategies, are most effective for BP control in patients with hypertension and should be used to improve hypertension control.
Primary Funding Source:
National Institutes of Health.

http://ift.tt/2ByP0Bm

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.